Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
SkinBioTherapeutics ( (GB:SBTX) ) just unveiled an announcement.
SkinBioTherapeutics PLC has announced a change in voting rights following an acquisition or disposal by David Campbell Brierwood, who now holds 5.561% of the company’s voting rights, up from a previous 4.1%. This change in voting rights could potentially impact the company’s shareholder dynamics and influence future decision-making processes.
More about SkinBioTherapeutics
SkinBioTherapeutics PLC is a UK-based company operating in the biotechnology industry, focusing on developing technology and products that harness the microbiome to improve skin health.
YTD Price Performance: 8.65%
Average Trading Volume: 842,875
Technical Sentiment Consensus Rating: Sell
Current Market Cap: £45.92M
See more data about SBTX stock on TipRanks’ Stock Analysis page.